Definitive Contract HR001118C0045
- Not listed
- This federal contract award, valued at $24,582,734.00, was made by the Defense Advanced Research Projects Agency (DARPA) to the Georgia Tech Applied Research Corporation (GTARC) to develop the Tactical Rapid Pathogen Identification and Diagnostic Ensemble (TRIAGE) under DARPA's Detect It with Gene Editing Technologies (DIGET) program. The DIGET program seeks to leverage gene editing technologies to create low-cost, highly sensitive, rapidly reconfigurable diagnostics and biosurveillance...
- This is a definitive contract awarded by the Department of Defense (DOD) Missile Defense Agency to General Atomics, a manufacturer of goods located in San Diego, California. The $133,171,741.54 cost-plus-award-fee contract is for research and development labor support. No set-aside designation was used. As a prime contractor, General Atomics provides the DOD and other agencies with a wide range of advanced technology solutions, including aircraft launch and recovery systems, unmanned vehicles,...
- This is a $1,324,670.00 cost plus fixed fee contract awarded by the Defense Threat Reduction Agency (DTRA) to General Atomics, a leading defense and technology company headquartered in San Diego, California. The contract is for the development of "THERMITE/METAL FOAM FOR BULK NEUTRALIZATION OF C/B AGENTS", which indicates the delivery of advanced materials and technologies to support the neutralization of chemical and biological agents. The contract does not have a set-aside...
- This is a firm fixed-price delivery order awarded by the Uniformed Services University of the Health Sciences, a defense agency, to General Atomics, a large defense and technology company. The $353,273.97 contract supports a license amendment request and additional reporting for the Armed Forces Radiobiology Research Institute (AFRRI). This contract does not have a set-aside designation. General Atomics has several significant Indefinite Delivery Vehicles with various federal agencies, including...
- This is a $3,119,876.00 definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to General Electric Company (GE) for the development of a "PORTABLE, REAL TIME, SINGLE CELL ANTIMICROBIAL SUSCEPTIBILITY TESTING" system. The contract has a period of performance through December 1, 2018 and uses a cost-no-fee pricing type. GE's GE Research division is the performing entity, and the contract was not set aside for small businesses. This award is part of GE's broader federal...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to General Atomics, a leading defense and technology company. The contract, valued at $36,100.00, is for the provision of light indicator devices. The contract has an ultimate completion date of December 19, 2025. General Atomics, headquartered in San Diego, California, is a manufacturer of specialized components and systems for various government agencies, including the Department of Defense,...
- This federal contract award is a purchase order valued at $103,748.00 issued by the Defense Logistics Agency Aviation to the prime contractor, General Atomics, for the delivery of a transducer, motional. General Atomics is a for-profit organization and manufacturer of goods based in San Diego, California. The contract is a firm fixed-price agreement with a completion date of February 13, 2023. General Atomics holds several Indefinite Delivery Vehicles (IDVs) with the Department of Defense,...
- General Atomics has been awarded a delivery order valued at $741,322.43 to provide instrumentation repair services in support of Armed Forces Radiobiology Research Institute (AFRRI) TRIGA Reactor operations. The contract, awarded on September 20, 2024, with an ultimate completion date of December 31, 2025, is funded by the Uniformed Services University of the Health Sciences under a firm fixed-price arrangement with no set-aside designation. Work will be performed in Bethesda, Maryland, and...
- The Defense Advanced Research Projects Agency awarded a $998,648 other transaction agreement to the Georgia Tech Applied Research Corporation, doing business as Gtarc, to deliver a bioaerosol collector for SARS-CoV-2 detection. As the prime contractor, Gtarc will perform the work under the oversight of the Defense Advanced Research Projects Agency. The contract has a period of performance from January 30, 2021 through October 30, 2022 and utilizes a pricing structure other than typical fixed...
- This is a $1,149,591.28 fixed-price level of effort contract awarded by the U.S. Army Contracting Command (ACC) to General Atomics, a large defense and technology company. The contract is under the Small Business Innovation Research (SBIR) program, specifically for a Phase II effort. The contract has a place of performance in Longmont, Colorado and an ultimate completion date of September 22, 2022. General Atomics is the prime contractor on this SBIR Phase II contract, which was set aside for...
This is a $4,470,383.00 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to General Atomics, a leading defense and technology company headquartered in San Diego, California. The contract, titled "PROMETHEUS", tasks General Atomics with developing a hand-held, field-portable diagnostic instrument capable of performing nucleic acid-based tests for panels of pathogens associated with febrile illness. This diagnostic instrument is being developed to host panel diagnostic tests for pathogens endemic to the Americas and Africa, with the goal of dramatically impacting troop care around the world. The contract does not have a set-aside designation, reflecting General Atomics' status as a large, established defense contractor. The contract has a period of performance ending on March 31, 2023. General Atomics has been awarded a subcontract for crating services related to this contract.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Use of Structured Light Pulses for the Selective Noninvasive Neutralization of Pathogens | HR001117S0030 | Defense Advanced Research Projects Agency | Award Notice 2/2 | 6/28/18, 10:44 AM | |
Biological Technologies | HR001117S0030 | Defense Advanced Research Projects Agency | Award Notice 1/2 | 4/26/17, 2:50 PM |
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
4500075910S | None | Definitive Contract HR001118C0045 | $124.0k | 9/20/18 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00016 | Change Order | $0 | 12/1/22 | |
| P00015 | Other Administrative Action | $0 | 8/29/22 | |
| P00014 | Supplemental Agreement for work within scope | $0 | 3/30/22 | |
| P00013 | Other Administrative Action | $0 | 3/3/22 | |
| P00012 | Supplemental Agreement for work within scope | $846.7k | 12/22/21 |